Cargando…

Can Metabolic Pathways Be Therapeutic Targets in Rheumatoid Arthritis?

The metabolic rewiring of tumor cells and immune cells has been viewed as a promising source of novel drug targets. Many of the molecular pathways implicated in rheumatoid arthritis (RA) directly modify synovium metabolism and transform the resident cells, such as the fibroblast-like synoviocytes (F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanchez-Lopez, Elsa, Cheng, Anyan, Guma, Monica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572063/ https://www.ncbi.nlm.nih.gov/pubmed/31137815 http://dx.doi.org/10.3390/jcm8050753

Ejemplares similares

Fibroblast-Like Synoviocytes Glucose Metabolism as a Therapeutic Target in Rheumatoid Arthritis
por: de Oliveira, Patricia Gnieslaw, et al.
Publicado: (2019)

Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis
por: Bustamante, Marta F., et al.
Publicado: (2017)

Future therapeutic targets in rheumatoid arthritis?
por: Cheung, Tommy Tsang, et al.
Publicado: (2017)

Circulating Pro- and Anti-Inflammatory Metabolites and Its Potential Role in Rheumatoid Arthritis Pathogenesis
por: Coras, Roxana, et al.
Publicado: (2020)

Solute carrier nutrient transporters in rheumatoid arthritis fibroblast-like synoviocytes
por: Torres, Alyssa, et al.
Publicado: (2022)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
por: Dayer, Jean-Michel, et al.
Publicado: (2010)

Adipokines in Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets
por: Bilski, Jan, et al.
Publicado: (2023)

Role of mitochondria-bound HK2 in rheumatoid arthritis fibroblast-like synoviocytes
por: Torres, Alyssa, et al.
Publicado: (2023)

Metabolic Syndrome in Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2013)

Possible Future Avenues for Rheumatoid Arthritis Therapeutics: Hippo Pathway
por: Wang, Tao, et al.
Publicado: (2023)

Docking and Molecular Dynamics Study to Identify Novel Phytobiologics from Dracaena trifasciata against Metabolic Reprogramming in Rheumatoid Arthritis
por: Ahmed, Shanzay, et al.
Publicado: (2022)

RANKL is a therapeutic target of bone destruction in rheumatoid arthritis
por: Tanaka, Sakae
Publicado: (2019)

Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets
por: Alunno, Alessia, et al.
Publicado: (2017)

Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis
por: Zhang, Fen, et al.
Publicado: (2023)

Signaling pathways in rheumatoid arthritis: implications for targeted therapy
por: Ding, Qian, et al.
Publicado: (2023)

DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis
por: Ciechomska, Marzena, et al.
Publicado: (2019)

Therapeutic implications of autoantibodies in rheumatoid arthritis
por: Aletaha, Daniel, et al.
Publicado: (2016)

Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis
por: Sweeney, Shannon R, et al.
Publicado: (2016)

Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
por: Huang, Jie, et al.
Publicado: (2021)

Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis
por: Jiang, Qi, et al.
Publicado: (2022)

Targeting Probiotics in Rheumatoid Arthritis
por: Bungau, Simona Gabriela, et al.
Publicado: (2021)

Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis
por: Kim, Kyoung-Woon, et al.
Publicado: (2016)

Design of an anti-inflammatory diet (ITIS diet) for patients with rheumatoid arthritis
por: Bustamante, Marta F., et al.
Publicado: (2020)

Metabolites and metabolic pathways associated with rheumatoid arthritis and systemic lupus erythematosus
por: Duarte-Delgado, Nancy P., et al.
Publicado: (2022)

Current Therapeutic Options in the Treatment of Rheumatoid Arthritis
por: Köhler, Birgit M., et al.
Publicado: (2019)

Interleukin-18: a therapeutic target in rheumatoid arthritis?
por: McInnes, Iain B, et al.
Publicado: (2005)

Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
por: Balendran, Thivya, et al.
Publicado: (2023)

Emerging role of targeting macrophages in rheumatoid arthritis: Focus on polarization, metabolism and apoptosis
por: Yang, Xuezhi, et al.
Publicado: (2020)

Metabolic Reprogramming of Fibroblasts as Therapeutic Target in Rheumatoid Arthritis and Cancer: Deciphering Key Mechanisms Using Computational Systems Biology Approaches
por: Aghakhani, Sahar, et al.
Publicado: (2020)

New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis
por: Hascoët, Emilie, et al.
Publicado: (2023)

Abnormal Glucose Metabolism in Rheumatoid Arthritis
por: Pi, Hui, et al.
Publicado: (2017)

Lipid metabolism and rheumatoid arthritis
por: Lei, Qian, et al.
Publicado: (2023)

Can pyroptosis be a new target in rheumatoid arthritis treatment?
por: Wu, Dengqiang, et al.
Publicado: (2023)

The interplay between inflammation and metabolism in rheumatoid arthritis
por: Chimenti, M S, et al.
Publicado: (2015)

Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis
por: Narasimhan, Rekha, et al.
Publicado: (2018)

Exosomes as Rheumatoid Arthritis Diagnostic Biomarkers and Therapeutic Agents
por: Heydari, Romina, et al.
Publicado: (2023)

Rheumatoid arthritis: the old issue, the new therapeutic approach
por: Babaahmadi, Mahnaz, et al.
Publicado: (2023)

Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis
por: Williams, Richard O.
Publicado: (2013)

Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment
por: Shen, Haotian, et al.
Publicado: (2022)

Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
por: Ahmed, Shanzay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gmivuji30p56gjmvmq5fl1b3c7